Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Divestments: 2020-2021

Historic Divestments for Agios Pharmaceuticals (AGIO) over the last 1 years, with Mar 2021 value amounting to $1.8 billion.

  • Agios Pharmaceuticals' Divestments rose 696214.29% to $1.8 billion in Q1 2021 from the same period last year, while for Mar 2021 it was $1.8 billion, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q1 2021, Agios Pharmaceuticals' Divestments is $1.8 billion, which was up 396,349.67% from -$455,000 recorded in Q4 2020.
  • Agios Pharmaceuticals' Divestments' 5-year high stood at $1.8 billion during Q1 2021, with a 5-year trough of -$455,000 in Q4 2020.
  • Its 2-year average for Divestments is $450.5 million, with a median of -$174,000 in 2020.
  • Data for Agios Pharmaceuticals' Divestments shows a peak YoY skyrocketed of 696,214.29% (in 2021) over the last 5 years.
  • Over the past 2 years, Agios Pharmaceuticals' Divestments (Quarterly) stood at -$455,000 in 2020, then skyrocketed by 696,214.29% to $1.8 billion in 2021.
  • Its Divestments stands at $1.8 billion for Q1 2021, versus -$455,000 for Q4 2020 and -$89,000 for Q2 2020.